ArticleScientific reports2025
The study of inorganic absorber layers in perovskite solar cells: the influence of CdTe and CIGS incorporation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Numerical optimization of RbRSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The perovskite solar cell has been the subject of intense breakdown lately because of its exceptional efficiency. Nevertheless, they confront a significant challenge due to the absorber layer's (perovskite) sensitivity to oxygen and water, which can cause rapid material degradation and adversely affect the solar cell's performance. The commonly used organic hole transport layer (HTL), Spiro-OMeTAD, tends to degrade over time, exacerbating the issue. To address this challenge, two-stage research was conducted. Initially, the CH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.